Weight Loss News and Research

Latest Weight Loss News and Research

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.

20 Sep 2011

California schools bar children without whooping cough shots

...

19 Sep 2011

Nutracheck launches UK's first weight loss App

The UK's first weight loss App that scans barcodes on food products has been launched by Nutracheck.co.uk.

19 Sep 2011

USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations

The U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance related to Cenestra Health's high-purity omega-3 fatty acid formulations and their methods of use.

19 Sep 2011

Multiple abstracts on QNEXA presented at 47th EASD

VIVUS, Inc. today announced that multiple abstracts were presented at the 47th European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal. The presentations highlighted the long-term beneficial effects of QNEXA treatment in metabolically-impaired patients with prediabetes, diabetes, and metabolic syndrome.

17 Sep 2011

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

Thanks to greater awareness, earlier detection and improving therapeutic agents, people with cancer are living longer than ever before. One of the consequences of living longer is the symptom burden of cancer survivorship, which may have a substantial impact on quality of life for many survivors. One such burden is the pain syndromes resulting from cancer treatments.

17 Sep 2011

Enrollment commences in ConjuChem's CJC-1134-PC Phase 2 trial for Type 2 diabetes

ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.

15 Sep 2011

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.

12 Sep 2011

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Genentech, a member of the Roche Group, today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

12 Sep 2011

‘Weight Watchers’ twice as effective in weight loss as standard care: Study

A new study published this Thursday shows that overweight patients told by their doctors to go to Weight Watchers lose around twice as much weight as people receiving standard weight loss care over 12 months.

9 Sep 2011

Weight Watchers more effective alternative to primary care for obese adults

A new, one-year global study published today in The Lancet indicates that overweight and obese adults referred to Weight Watchers, a community based provider of weight-loss services, lost more than twice as much weight when compared with those who received standard care.

9 Sep 2011

Pancreatic cancer outcomes poor in UK – experts urge better diagnosis and treatment

A new report reveals that survival rates in the UK for people with pancreatic cancer are among the worst in the world. The report recommends earlier diagnosis and better treatment.

8 Sep 2011

HHS Secretary tours Alaska health care facilities; judge halts rollback of Ariz. same-sex benefits

Alaska has a message for HHS Secretary Kathleen Sebelius: Don't assume that health care delivery reform can work the same way in every state. That's the lesson Sen. Mark Begich says he tried to impart to Sebelius as he toured some of the state's health and early child care centers with her last week. Sebelius went to learn first-hand about the state's health services, the Indian Health Service, and how the health law is being implemented.

8 Sep 2011

Social engagement transforms white fat into energy-burning brown fat

When mice are given a more engaging place to live with greater opportunities for social stimulation, some of their energy-storing white fat is transformed to energy-burning brown fat. As a result, the animals expend more energy and lose weight even as they eat more. The findings reported in the September Cell Metabolism, a Cell Press publication, point to the powerful effect that animals' social and physical environments can have on their metabolisms.

8 Sep 2011

Duodenal switch may lead to more weight loss but more complications: Study

A less usual and common type of obesity surgery may spur more weight loss than its far more popular cousin, gastric bypass - but at the price of greater long-term risks, researchers reported.

6 Sep 2011

Diabetes prevention in five steps: Study

According to a new study meeting just one of five key health goals reduces the odds of developing diabetes in middle age by roughly one-third. The report adds that the more goals are met the lower the risk falls, even if there is a family history of diabetes.

6 Sep 2011

Bariatric surgery is cost-effective but has long-term complications

The majority of people who undergo bariatric weight-loss surgery benefit from the procedure, but long-term complications and further surgery are not uncommon, according to a UK paper on late postoperative complications in the October issue of BJS, the British Journal of Surgery.

6 Sep 2011

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.

6 Sep 2011

Hospitals with higher surgical volumes less likely to cause unintentional serious injuries

Are you scheduled for heart bypass surgery or weight loss surgery? You might want to find out just how frequently different hospitals in your area are performing those procedures before deciding where to go. A new study finds that hospitals with higher surgical volumes for certain procedures are less likely to cause unintentional serious injuries to hospitalized patients when compared to those hospitals that perform the procedures less often.

2 Sep 2011

Aerobic exercise best for belly fat reduction: Study

A new study has shown that the best type of exercise to burn unhealthy belly fat is aerobic exercise. The results showed that people who did aerobics for eight months lost about 2.5 square inches of belly fat, as measured on a CT scan. That's about 1.5 times as much as people who did a combination of aerobic exercise and weight lifting, and about 20 times as much as those who only lifted weights.

31 Aug 2011

Weight Loss News and Research

Latest Weight Loss News and Research

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

California schools bar children without whooping cough shots

Nutracheck launches UK's first weight loss App

USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations

Multiple abstracts on QNEXA presented at 47th EASD

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

Enrollment commences in ConjuChem's CJC-1134-PC Phase 2 trial for Type 2 diabetes

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

‘Weight Watchers’ twice as effective in weight loss as standard care: Study

Weight Watchers more effective alternative to primary care for obese adults

Pancreatic cancer outcomes poor in UK – experts urge better diagnosis and treatment

HHS Secretary tours Alaska health care facilities; judge halts rollback of Ariz. same-sex benefits

Social engagement transforms white fat into energy-burning brown fat

Duodenal switch may lead to more weight loss but more complications: Study

Diabetes prevention in five steps: Study

Bariatric surgery is cost-effective but has long-term complications

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

Hospitals with higher surgical volumes less likely to cause unintentional serious injuries

Aerobic exercise best for belly fat reduction: Study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Weight Loss News and Research

Latest Weight Loss News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in